Article 50

An extension to Article 50 would benefit pharmaceutical manufacturers trading with Europe, according to an industry logistics expert. Read more


Independent advocate for science and engineering, CaSE, has published a new Brexit report with policy requests from the science and engineering sector on people, funding and regulation, to mark the anniversary of the triggering of article 50. Read more


As the industry realigns itself to some major changes, EPM magazine also has a shake up. Read more


In response to the triggering of Article 50 by the Prime Minister yesterday, the UK BioIndustry Association (BIA) has stated that ‘the fundamentals of UK bioscience remain strong’. Read more